Kyndryl Holdings Inc. is not a good buy for a beginner investor with a long-term strategy at this time. The company is facing significant challenges, including management instability, financial reporting issues, and negative sentiment from analysts. While there are some positive indicators like slight revenue growth and hedge fund interest, the risks outweigh the potential rewards given the investor's profile and goals.
The MACD is positive and expanding, indicating bullish momentum, but the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 13.396), suggesting limited upside potential in the short term.

Solas Capital Management recently acquired a significant position in Kyndryl, showing some institutional interest. Revenue increased by 3.07% YoY in Q3 2026.
Key executive departures (CFO and General Counsel), delayed financial filings, SEC scrutiny, class action lawsuits, and material weaknesses in internal controls. Analysts have downgraded the stock and lowered price targets significantly. Negative sentiment is reinforced by poor financial performance, including a 73.49% YoY drop in net income.
In Q3 2026, revenue grew by 3.07% YoY to $3.86 billion, but net income dropped by 73.49% YoY to $57 million. EPS declined by 71.91% YoY to $0.25. Gross margin improved slightly to 21.85%, up 7.21% YoY.
Analysts have downgraded the stock significantly, citing management instability, financial reporting issues, and reduced guidance. Price targets have dropped sharply, with some firms removing their targets entirely. The overall sentiment is highly negative.